tirzepatide glp-1 gip Beyond glycemia: Comparing to analogues weekly GLP Frontiers | Clinical perspectives on

1 summarizes the several characteristics between single agonism using GLP-1 and dual agonism of GLP-1/GIP (i.e., tirzepatide) treatment

They may prescribe an anti-nausea medicine to help

BMI (Body Mass index) measures weight in relation to height

doi: 10.1210/jcem.87.3.8355 132 de HeerJRasmussenCCoyDHHolstJJ

134979-01-4, CH2COOH-PEG2-NH2.HCl References: [1] Tirzepatide demonstrated significant and superior weight loss compared to placebo in two pivotal studies, [2] Lilly's tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in SURMOUNT-2

However, the gastric emptying delay is most pronounced in the first 24 to 48 hours after injection